De Novo device
Embosphere Microspheres
Biosphere Medical, S.A. · Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia (NOY, Class II) · First FDA decision Jun 21, 2017, newest Jun 21, 2017Enlarged prostate (BPH)
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
31
Naming "Embosphere Microspheres"
MAUDE reports
41
Brand "Embosphere Microspheres", since 2015
PubMed studies
49
Mentioning "Embosphere Microspheres"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Embosphere Microspheres
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Embosphere MicrospheresNew device typeDe Novo
DEN160040 · Decided Jun 21, 2017 · 320 days after receipt
Device type: Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia (NOY) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)Local determinationIn effectL38378CGS Administrators, LLCUpdated Mar 25, 2026
- Erythropoiesis Stimulating Agents (ESAs) for Treatment of Anemia in Adults with CKD Including Patients on Dialysis and Patients not on DialysisNational analysisReview closedCAG-00413NUpdated Sep 17, 2026
- PSA (Addition of ICD-9-CM 600.21, Benign localized hyperplasia of prostate with urinary obstruction as a covered indication)Coding analysisReview closedCAG-00332NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Embosphere Microspheres", any status and sponsor, newest update first.
- Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery EmbolizationActive, not recruiting
H. Lee Moffitt Cancer Center and Research InstituteAcademic, hospital or other
NCT04879940 · 17 participants · Start Feb 23, 2022 · Primary completion Jun 16, 2026
Device: Merit Medical Embospheres · For: Prostate Carcinoma; Benign Prostatic Hyperplasia
Sites: Tampa, Florida
University of MiamiAcademic, hospital or other
NCT05112926 · 9 participants · Start Dec 8, 2022 · Primary completion Jun 2, 2026
Device: Embosphere Microspheres · For: Knee Osteoarthritis
Sites: Miami, Florida
Northwestern UniversityAcademic, hospital or other
NCT07537153 · 15 participants (planned) · Start Jul 10, 2026 · Primary completion Apr 10, 2028
Device: Embosphere Microspheres · For: Osteoarthritis; Knee Osteoarthritis
Sites: Chicago, Illinois
28 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Embosphere Microspheres", and for the whole product code for context.
This brand
41 reports: 5 malfunction, 36 injury, 0 death
Whole product code NOY
3 reports: 0 malfunction, 2 injury, 1 death
Newest reports for this brand
- EMBOSPHERE MICROSPHERESInjury
9615728-2021-00037 · Received Jun 16, 2021 · Event dated Apr 15, 2021
Device type: Agents, Embolic, For Treatment Of Uterine Fibroids (NAJ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Thrombosis/Thrombus
- EMBOSPHERE MICROSPHERESInjury
9615728-2020-00003 · Received Feb 27, 2020 · Event dated Jan 7, 2020
Device type: Device, Vascular, For Promoting Embolization (KRD)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Blood Loss
- EMBOSPHERE MICROSPHERESInjury
9615728-2020-00002 · Received Feb 14, 2020 · Event dated Dec 19, 2019
Device type: Device, Neurovascular Embolization (HCG)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Fever; Unspecified Infection
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Embosphere Microspheres"[tiab]. The summary above synthesizes these.
- [Dural Arteriovenous Fistula:Endovascular Techniques and Devices].
Izumi T · No Shinkei Geka · 2023English Abstract
- Embolization of Skull Base Meningiomas with Embosphere Microspheres: Factors Predicting Treatment Response and Evaluation of Complications.
Okada H, Hashimoto T, Tanaka Y, et al. · World Neurosurg · 2022
- Embosphere microspheres size for bronchial artery embolization in patients with hemoptysis caused by bronchiectasis: a retrospective comparative analysis of 500-750 versus 700-900 μm microspheres.
Xu HD, Yang L, Hu SB · BMC Pulm Med · 2024Comparative Study
- Embosphere Size Selection and Dilution Rate in Preoperative Tumor Embolization of the External Carotid Artery System Using a Small-diameter Catheter.
Hashimoto T, Arai Y, Okada H, et al. · Neurol Med Chir (Tokyo) · 2025
- Clinical Study on the Treatment of Benign Prostatic Hyperplasia by Embolization of Prostate Artery Based on Embosphere Microspheres and Gelatin Sponge Granules.
Liu J, Shi D, Li L, et al. · J Healthc Eng · 2022Research Support, Non-U.S. Gov't
- Two-year outcomes comparing Embosphere® microspheres versus Imipenem Cilastatin for genicular artery embolization in patients with moderate to severe knee osteoarthritis.
Bhatia S, Jalaeian H, Kumar J, et al. · Knee · 2023
- Uterine artery embolization in sheep: comparison of acute effects with Embosphere microspheres and Embosoft microspheres.
Leite TFO, Messina ML, Takimura CK, et al. · Acta Radiol · 2025Comparative Study
- Prostatic Artery Embolization Using Embosphere Microspheres for Prostates Measuring 80-150 cm(3): Early Results from a US Trial.
Isaacson AJ, Raynor MC, Yu H, et al. · J Vasc Interv Radiol · 2016Clinical Trial
- Preoperative embolization of intracranial meningiomas with Embosphere microspheres.
Rodiek SO, Stölzle A, Lumenta ChB · Minim Invasive Neurosurg · 2004
- The arterial distribution of Embozene and Embosphere microspheres in sheep kidney and uterus embolization models.
Verret V, Ghegediban SH, Wassef M, et al. · J Vasc Interv Radiol · 2011Comparative Study
- Embosphere microsphere embolization of the middle meningeal artery for the treatment of chronic subdural hematoma: a single-center experience.
Xu L, Zhang D, Jiang Y, et al. · Front Neurol · 2025
- Investigation of the Physical Properties and Clinical Application of Embosphere Microspheres.
Hu Y, Zhao Z, Li S, et al. · Chemotherapy · 2021
Other devices of this type
Also filed under product code NOY.
- Bead Block (100 - 300µmBiocompatibles UK Ltd (Part of Boston Scientific Corporation · 510(k) 2021
- HydroPearl MicrospheresMicroVention, Inc. · 510(k) 2020
- Embozene Color-Advanced MicrospheresBoston Scientific · 510(k) 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.